Inactive Instrument

Press Releases IGNE ACQU

Equities

IGNY

US45175H1068

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

IGNE ACQU : Carve-out Condensed Consolidated Financial Statements As of and for the Six Months Ended June 30, 2022 and 2021 - Form 8-K	07/11/22	PU
IGNYTE ACQUISITION CORP. Submission of Matters to a Vote of Security Holders (form 8-K/A)	28/10/22	AQ
IGNYTE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	27/10/22	AQ
Ignyte Acquisition Corp. Stockholders Approve Proposed Business Combination with Peak Bio	27/10/22	BU
IGNE ACQU : Business Combination Agreement - Form 8-K	24/10/22	PU
IGNYTE ACQUISITION CORP. : Other Events (form 8-K)	24/10/22	AQ
Ignyte Acquisition : Purchase Agreement - Form 8-K	18/10/22	PU
IGNYTE ACQUISITION CORP. : Other Events (form 8-K)	18/10/22	AQ
IGNYTE ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	28/09/22	AQ
Ignyte Acquisition : Material Agreement - Form 8-K	21/09/22	PU
IGNYTE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	21/09/22	AQ
IGNYTE ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	15/08/22	AQ
IGNYTE ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	19/05/22	AQ
Ignyte Acquisition : Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company - Form 8-K	30/04/22	PU
IGNYTE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	29/04/22	AQ
Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company	28/04/22	BU
IGNYTE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	31/03/22	AQ
IGNYTE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	25/03/22	AQ
IGNYTE ACQUISITION CORP. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	16/11/21	AQ
IGNYTE ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	15/11/21	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IGNE ACQU

Equities

IGNY

US45175H1068

Press Releases

Filters